Announcements Trials
Browse Landscape

Status

Unknown 1Not yet recruiting 1

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 12Rectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Ovarian Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Postoperative Complications 2Pathologic Complete Response 2Head and Neck Neoplasms 2Breast Cancer Patients 2Surgery 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1

Interventions

Neoadjuvant Therapy 2Proctectomy 1Positron Emission Tomography Computed Tomography 1Patient Reported Outcome Measures 1Observation 1Magnetic Resonance Imaging 1Independent Medical Evaluation 1Immunohistochemistry 1Immune Checkpoint Inhibitors 1Endoscopy 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pathologic Complete Response × Neoadjuvant Therapy × Clear all
NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
600 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

ChineseAMS

Unknown
1,821 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡